Related Experiment Video
Updated: Dec 13, 2025

Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells
Published on: June 13, 2020
Novel Bacillus strains from the human gut exert anticancer effects on a broad range of malignancy types
Man-Fei Zhao1, Gong-Da Liang1, Yu-Jie Zhou2,3
1Department of Epidemiology, Public Health School, Harbin Medical University, Harbin, Heilongjiang Province, China.
Abstract:
Cancer is one of the leading causes of death worldwide, but effective therapies remain the topic of many research activities. Many recent studies have thus focused on particular gut microbiota due to their important roles in treating cancers, but very few microbes of therapeutic value have been reported. In this study, we isolated four bacterial strains, BY38, BY40, BY43 and BY45, from the fecal specimens of healthy individuals and cancer patients. The treatment of cancer cells with the products of these cultured bacteria induced significant inhibitory effects on the proliferation of ovarian cancer cells and colorectal cancer cells in a dose-dependent manner. A phylogenetic analysis showed that the four anticancer strains belong to the genus Bacillus, and flow cytometry assays indicated that the inhibitory effects might be achieved through the induction of cell apoptosis. These results suggest that these bacteria could be novel and promising anticancer agents against cancers.
Insights
Researchers identified four novel Bacillus strains from fecal samples that inhibit the proliferation of ovarian and colorectal cancer cells. These gut bacteria show potential as promising new anticancer agents by inducing apoptosis.
Area of Science:
- Microbiology
- Oncology
- Gut Microbiome Research
Background:
- Cancer remains a leading global cause of mortality, necessitating novel therapeutic strategies.
- The gut microbiota's role in cancer treatment is increasingly recognized, yet few microbes with therapeutic potential have been identified.
Purpose of the Study:
- To isolate and characterize novel gut bacteria with potential anticancer properties.
- To evaluate the efficacy of isolated bacterial strains against ovarian and colorectal cancer cells.
Main Methods:
- Isolation of bacterial strains (BY38, BY40, BY43, BY45) from fecal specimens.
- In vitro assays to assess the impact of bacterial products on cancer cell proliferation.
- Phylogenetic analysis to identify bacterial species.
- Flow cytometry to investigate mechanisms of cell death induction (apoptosis).
Main Results:
- Bacterial strains BY38, BY40, BY43, and BY45 demonstrated significant, dose-dependent inhibition of ovarian and colorectal cancer cell proliferation.
- Phylogenetic analysis confirmed the strains belong to the genus Bacillus.
- Flow cytometry suggested that the anticancer effects are mediated through the induction of apoptosis.
Conclusions:
- The isolated Bacillus strains represent promising candidates for novel anticancer agents.
- Further research into these gut bacteria could lead to new therapeutic approaches for cancer treatment.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Abnormal Proliferation
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules

